Seetharama D. Jois - Concepedia

Author

Seetharama D. Jois

Also Known As

Jois, Seetharama D., S. D. S. Jois, S. Jois, S.D.S. Jois, Seetharama D Jois, Seetharama D S Jois, Seetharama D. Jois, Seetharama D. S. Jois, Seetharama D.S Jois, Seetharama D.S. Jois

109

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Louisiana at Monroe National University of Singapore Louisiana State University University of Kansas Louisiana State University Health Sciences Center Shreveport

About

Seetharama D. Jois is an author at University of Louisiana at Monroe specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	946
2	Natural Sciences	6	6	208
3	Biochemistry	6	6	206
4	Engineering	4	4	133
5	Allergy	1	1	17

Seetharama D. Jois

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections Farhana Musarrat, Vladimir N. Chouljenko, Achyut Dahal, Journal of Medical Virology Covid‐19 InfectionsImmunodeficienciesViral PathogenesisImmunologyPathology	2020	158
An N-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells Mohammad B. Uddin, Kartik R. Roy, Salman B. Hosain, Biochemical Pharmacology Tumor BiologyOncogenic AgentMedicineMolecular BiologyCancer Cells	2018	108
Peptides Derived from Human Decorin Leucine-rich Repeat 5 Inhibit Angiogenesis Konerirajapuram Natarajan Sulochana, Huapeng Fan, Seetharama D. Jois, Journal of Biological Chemistry ImmunologyPeptide ScienceEndothelial Cell AttachmentAngiogenesisFibroblast Growth Factor	2005	83
Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor Khaldoun S. Abdelwahed, Abu Bakar Siddique, Mohamed M. Mohyeldin, Pharmacological Research Breast OncologyHormonal ReceptorImmunologyPcsk9 SecretionNovel Suppressor	2020	80
Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells Ning Zhao, Tyrslai M. Williams, Zehua Zhou, Bioconjugate Chemistry	2017	63
Increasing Paracellular Porosity by E-Cadherin Peptides: Discovery of Bulge and Groove Regions in the EC1-Domain of E-Cadherin Ernawati Sinaga, Seetharama D. Jois, M P Avery, Pharmaceutical Research	2002	63
GHRH antagonists support lung endothelial barrier function Mohammad A. Uddin, Mohammad S. Akhter, Sitanshu S. Singh, Tissue Barriers	2019	60
Solution Structure of a Cyclic RGD Peptide That Inhibits Platelet Aggregation Seetharama D. Jois, Usman Sumo Friend Tambunan, Soma Chakrabarti, Journal of Biomolecular Structure and Dynamics	1996	59
The effect of conformation on the membrane permeation of coumarinic acid‐ and phenylpropionic acid‐based cyclic prodrugs of opioid peptides O.S. Gudmundsson, Seetharama D. Jois, David G. Vander Velde, Journal of Peptide Research	1999	56
Separation and Analysis of Peptides and Proteins Christian Schöneich, Andreas F. R. Hühmer, Shelley R. Rabel, Analytical Chemistry Peptide EngineeringProtein AnalysisBiological Mass SpectrometryAltmetric Attention ScorePeptide Science	1995	51

Page 1